BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8157005)

  • 1. Differential transactivation potential of Oct1 and Oct2 is determined by additional B cell-specific activities.
    Pfisterer P; Annweiler A; Ullmer C; Corcoran LM; Wirth T
    EMBO J; 1994 Apr; 13(7):1654-63. PubMed ID: 8157005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The POU domains of the Oct1 and Oct2 transcription factors mediate specific interaction with TBP.
    Zwilling S; Annweiler A; Wirth T
    Nucleic Acids Res; 1994 May; 22(9):1655-62. PubMed ID: 8202368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oct2 transactivation from a remote enhancer position requires a B-cell-restricted activity.
    Annweiler A; Müller-Immerglück M; Wirth T
    Mol Cell Biol; 1992 Jul; 12(7):3107-16. PubMed ID: 1620119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1.
    Pfisterer P; Zwilling S; Hess J; Wirth T
    J Biol Chem; 1995 Dec; 270(50):29870-80. PubMed ID: 8530384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISP-3, a protein with homology to plant defense proteins, is expressed in mouse B cells under the control of Oct2.
    Pfisterer P; König H; Hess J; Lipowsky G; Haendler B; Schleuning WD; Wirth T
    Mol Cell Biol; 1996 Nov; 16(11):6160-8. PubMed ID: 8887646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of transcriptional stimulation by recombinant Oct proteins in a cell-free system.
    Annweiler A; Zwilling S; Hipskind RA; Wirth T
    J Biol Chem; 1993 Feb; 268(4):2525-34. PubMed ID: 8428930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High mobility group protein 2 functionally interacts with the POU domains of octamer transcription factors.
    Zwilling S; König H; Wirth T
    EMBO J; 1995 Mar; 14(6):1198-208. PubMed ID: 7720710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular principles of Oct2-mediated gene activation in B cells.
    Wirth T; Pfisterer P; Annweiler A; Zwilling S; König H
    Immunobiology; 1995 Jul; 193(2-4):161-70. PubMed ID: 8530140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive transcriptional control elements within the SP6 kappa promoter decamer 3' flanking sequence.
    Sigvardsson M; Leanderson T
    Mol Immunol; 1994 Sep; 31(13):1005-16. PubMed ID: 8084335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphoid- and myeloid-specific activity of the PU.1 promoter is determined by the combinatorial action of octamer and ets transcription factors.
    Kistler B; Pfisterer P; Wirth T
    Oncogene; 1995 Sep; 11(6):1095-106. PubMed ID: 7566969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bob1 (OCA-B/OBF-1) differential transactivation of the B cell-specific B29 (Ig beta) and mb-1 (Ig alpha) promoters.
    Malone CS; Wall R
    J Immunol; 2002 Apr; 168(7):3369-75. PubMed ID: 11907094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of an Oct1 orthologue in the channel catfish, Ictalurus punctatus: a negative regulator of immunoglobulin gene transcription?
    Lennard ML; Hikima J; Ross DA; Kruiswijk CP; Wilson MR; Miller NW; Warr GW
    BMC Mol Biol; 2007 Jan; 8():8. PubMed ID: 17266766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional differences between the Oct2 transactivation domains determine the transactivation potential of individual Oct2 isoforms.
    Annweiler A; Zwilling S; Wirth T
    Nucleic Acids Res; 1994 Oct; 22(20):4250-8. PubMed ID: 7937153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octamer independent activation of transcription from the kappa immunoglobulin germline promoter.
    Prabhu A; O'Brien DP; Weisner GL; Fulton R; Van Ness B
    Nucleic Acids Res; 1996 Dec; 24(23):4805-11. PubMed ID: 8972869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octamer binding protein 2 (Oct2) regulates PD-L2 gene expression in B-1 cells through lineage-specific activity of a unique, intronic promoter.
    Kaku H; Rothstein TL
    Genes Immun; 2010 Jan; 11(1):55-66. PubMed ID: 19710692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HS1,2 enhancer regulation of germline epsilon and gamma2b promoters in murine B lymphocytes: evidence for specific promoter-enhancer interactions.
    Laurencikiene J; Deveikaite V; Severinson E
    J Immunol; 2001 Sep; 167(6):3257-65. PubMed ID: 11544313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catfish Oct2 binding affinity and functional preference for octamer motifs, and interaction with OBF-1.
    Ross DA; Lyles M; Ledford BE; Magor BG; Wilson MR; Miller NW; Clem LW; Middleton DA; Warr GW
    Dev Comp Immunol; 1999 Apr; 23(3):199-211. PubMed ID: 10402207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of Oct-1 with TFIIB. Implications for a novel response elicited through the proximal octamer site of the lipoprotein lipase promoter.
    Nakshatri H; Nakshatri P; Currie RA
    J Biol Chem; 1995 Aug; 270(33):19613-23. PubMed ID: 7642649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation.
    Gstaiger M; Georgiev O; van Leeuwen H; van der Vliet P; Schaffner W
    EMBO J; 1996 Jun; 15(11):2781-90. PubMed ID: 8654375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concerted repression of an immunoglobulin heavy-chain enhancer, 3' alpha E(hs1,2).
    Singh M; Birshtein BK
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4392-7. PubMed ID: 8633077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.